A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s disease
Abstract Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder. However, current treatments only manage symptoms and lack the ability to slow or prevent disease progression. We utilized a systems genetics approach to identify potential risk genes and repurposable drugs for...
Saved in:
Main Authors: | Lijun Dou, Zhenxing Xu, Jielin Xu, Chengxi Zang, Chang Su, Andrew A. Pieper, James B. Leverenz, Fei Wang, Xiongwei Zhu, Jeffrey Cummings, Feixiong Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-025-00870-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01) -
Research progress in drug repurposing in the treatment of breast cancer
by: TAN Chen, et al.
Published: (2024-11-01) -
Pathobiology of Anaplastic Large Cell Lymphoma
by: Pier Paolo Piccaluga, et al.
Published: (2010-01-01) -
Contribution of Gut Bacteria to Liver Pathobiology
by: Gakuhei Son, et al.
Published: (2010-01-01) -
Pathobiology of Helicobacter pylori Infection in Children
by: Robert H Riddell
Published: (1999-01-01)